BD VeritorTM System RSV and Quidel
® Sofia
® RSV FIA are the widely used lateral flow digital immunoassay (DIA) tests for RSV viral antigens throughout the world. Neena Kanwar et al. compared the diagnostic accuracy of the two DIA tests with the real-time RT-PCR assay results as a reference, showing a sensitivity of 71.15% for BD VeritorTM System and 80.77% for Quidel
® Sofia
® RSV FIA system, and the specificity of 100% for both systems (
15). The sensitivity and specificity of the nCounter (NanoString Technologies), which is a multiplex digital method of RNA quantification, in comparison to real-time RT-PCR were found to be 74.3% and 98.4% for RSV-A, 77.6% and 97.8% for RSV-B, respectively (
16). Compared with the results of those studies, the colloidal-gold-Genesis showed higher sensitivity and lower specificity with a higher Youden index. Thus, the colloidal-gold-Genesis is a good alternative for the clinical quick screening of RSV infection for its high specificity, sensitivity and time-saving. Furthermore, the median CT value for the specimens in the colloidal positive group was significantly lower than the negative group. The higher the CT value, the lower is the RSV titer, thus the result tested by colloidal-gold-Genesis is not credible enough, especially when the RSV titer is low, which needs another test for confirmation, that’s why colloidal-gold-Genesis is a fast screening assay rather than a confirmation assay.
The RSV nucleic acid detection assay (real-time RT-PCR-IngeniGen) detected a total of 168 positive samples with 2 of them determined incorrectly, and 90 identified correctly negative samples. The sensitivity and specificity were found to be 100% and 97.8% respectively (
Table 1). The positive and negative likelihood ratio was 45.45 and 0.00 respectively. A higher statistical consistency was found between the real-time RT-PCR-HuaRuiAn and real-time RT-PCR-IngeniGen (kappa value = 0.983).
As shown in
Figure 1A, the CT value of colloidal gold assay positive group was significantly lower than that of the negative group (P ≤ 0.000). The median PCR CT value for the positive group was 24.18 (range 17.83 - 28.8), and for the negative group 27.45 (22.32 - 30.14). To determine the difference between the two real-time RT-PCR assays, the CT value was detected and analyzed. The median CT value of the 166 RSV positive samples which were detected by real-time RT-PCR-IngeniGen was 30.76 (range 25.72 - 37.42), while median CT value of real-time RT-PCR-HuaRuiAn was significantly lower (24.21, range 17.83 - 30.14; P ≤ 0.000) (
Figure 1B). Coming to the 2 incorrectly identified positive samples by real-time RT-PCR-IngeniGen, the CT value was 38.05 and 39.13 respectively. The 2 incorrectly identified positive samples by real-time RT-PCR-IngeniGen showed that the result of a positive sample may be inaccurate as the CT value higher than 38, suggesting that the outcome criteria of CT value should be more precise.
In future, the detection kit for RSV infection will develop towards fast, automatic, high sensitivity and specificity, as well as point-of-care testing (POCT). The colloidal-gold-Genesis is effective for early screening of RSV infection, while the newly developed RSV nucleic acid detection assay (real-time RT-PCR-IngeniGen) which is performed to confirm RSV infection should be more accurate in the definition of positive samples.